Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Rheumatic Diseases|April 14, 2025
Identification of BHLHE40-Expressing CD4+ T Cells Producing GM-CSF in Rheumatoid ArthritisSho Ishigaki, Katsuya Suzuki, Masaru Takeshita, et al.
Frontiers in Immunology|May 17, 2023
Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitorsKotaro Matsumoto, Katsuya Suzuki, Masaru Takeshita, et al.
Rheumatology and Therapy|October 18, 2016
Early Prognostic Factors Associated with the Efficacy of Infliximab Treatment for Patients with Rheumatoid Arthritis with Inadequate Response to MethotrexateSatoko Hayashi, Katsuya Suzuki, Keiko Yoshimoto, et al.
ACR Open Rheumatology|September 11, 2025
Anti-RuvBL1/2 Antibodies in Scleromyositis: A Clinicopathological Report of Two CasesYuki Imai, Masaru Takeshita, Yasushi Kondo, et al.
The Journal of Biological Chemistry|February 1, 2021
Potent mouse monoclonal antibodies that block SARS-CoV-2 infectionYoujia Guo, Atsushi Kawaguchi, Masaru Takeshita, et al.
Journal of Autoimmunity|May 25, 2021
Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune diseaseMasaru Takeshita, Katsuya Suzuki, Maho Nakazawa, et al.
Cytokine|June 23, 2015
Infliximab and etanercept have distinct actions but similar effects on cytokine profiles in rheumatoid arthritisMasaru Takeshita, Katsuya Suzuki, Jun Kikuchi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 28, 2026
Pediatric Rheumatic Disorders Revisited: Integrating Imaging and Pathophysiologic Insights across the Autoinflammatory-Autoimmune ContinuumYuko Tsujioka, Atsuhiko Handa, Gen Nishimura, et al.
Rheumatology Advances in Practice|January 5, 2026
Association of genetic variants with extravascular complications and cytokine production in Takayasu arteritis: a cross-sectional studyFarzana Shumy, Kotaro Matsumoto, Masaru Takeshita, et al.
Clinical Rheumatology|August 12, 2025
Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort studyYuichiro Ota, Masaru Takeshita, Yasushi Kondo, et al.
Pageof 5